iBio (IBIO) FCF Margin Growth (3y) (2014 - 2024)
iBio (IBIO) FCF Margin Growth (3y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.58 Bn | 466.79 Bn | 1.35 Bn | 15,064.00 |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.80 Bn | 50.61 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn | 6,066.00 |
| 10 | iBio | 166.24 Mn | 166.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -91,001.00 |
| Sep 30, 2023 | -885,341.00 |
| Mar 31, 2022 | 44,292.00 |
| Sep 30, 2021 | -1.01 Mn |
| Jun 30, 2021 | 196,904.00 |
| Mar 31, 2021 | 395,441.00 |
| Dec 31, 2020 | 112,822.00 |
| Sep 30, 2020 | 72,505.00 |
| Jun 30, 2020 | 249,356.00 |
| Mar 31, 2020 | 633,843.00 |
| Dec 31, 2019 | 378,861.00 |
| Sep 30, 2019 | -13,759.00 |
| Jun 30, 2019 | 47,743.00 |
| Mar 31, 2019 | -16,538.00 |
| Dec 31, 2018 | 47,295.00 |
| Sep 30, 2018 | -162,090.00 |
| Jun 30, 2018 | -357,142.00 |
| Mar 31, 2018 | -466,522.00 |
| Dec 31, 2017 | -202,089.00 |
| Sep 30, 2017 | -248,033.00 |